No more than 15 authors can be listed.Please ensure the authors are listed in the right order.If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.
The global success rate of tuberculosis (TB) treatment remains below target, particularly in drug-resistant TB (DR-TB). Identifying modifiable predictors of treatment success is essential to optimize outcomes. This study aimed to describe the clinical profile of DR-TB patients and determine factors associated with treatment success at a national referral respiratory center.
A retrospective cohort study was conducted using medical records of DR-TB patients treated at Persahabatan Hospital National Respiratory Center between 2022 and 2023. Demographic, clinical, and treatment-related variables were analyzed. Treatment outcomes were categorized according to standard definitions. Bivariate analysis was performed using the chi-square test, and odds ratios (OR) with 95% confidence intervals were calculated.
A total of 185 patients were included, with a mean age of 50.65±10.21 years; 58.4% were male. The majority had rifampicin-resistant TB (67%), followed by MDR-TB (22.7%) and XDR-TB (7.6%). Most patients received individualized regimens (67%), while 30.8% received short-course regimens. Treatment success (cured) was achieved in 61.6% of patients, while 15.1% experienced failure, 10.8% were lost to follow-up, and 12.5% died. Short-course regimens were significantly associated with higher treatment success (OR 1.92; p=0.045). Interestingly, unemployment was also independently associated with better outcomes (OR 2.85; p<0.001). HIV status and type of diabetes treatment were not significantly associated with treatment success.
In this study, DR-TB patients were predominantly older males with rifampicin resistance and moderate treatment success rates. Short-course regimens significantly improved outcomes, highlighting their potential as an effective strategy in programmatic settings. Socioeconomic factors, particularly employment status, also influenced treatment success, suggesting the need for tailored patient-centered interventions.